This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Humanities  • Medicine and the Media  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic

Arch Intern Med. 2005;165:2058-2060.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Considerable media attention has focused on recent research reports that statin-associated levels of C-reactive protein (CRP) are associated with prognosis after acute coronary syndrome.^1-2 Similar media attention to this topic is not new: the "CRP story" and reports of inflammation in general as related to heart disease have been repeatedly featured over the past several years in major print magazines, newspapers, and television news magazines. However, the most recent attention focused on this topic, including the relatively new phenomenon of "recommendations" made by popular media editorialists, raises 3 important concerns, 1 of which is elucidated by Miller et al³ in this issue of the ARCHIVES.

WHAT ARE CRP AND "HIGH-SENSITIVITY CRP" AND HOW DO THEY RELATE TO ATHEROSCLEROSIS?

The term C-reactive protein was coined in 1930 by Tillet and Frances, who first identified this protein as reactive with the "C" component of the pneumococcus bacterial coat.⁴ Since that time, evaluation of CRP level has become crucial to monitor inflammation such as . . . [Full Text of this Article]

DOES CRP REPRESENT A FUNDAMENTALLY NEW WAY TO VIEW HEART DISEASE?

WHEN SHOULD CRP BE MEASURED?

SHOULD CRP BE A SPECIFIC THERAPEUTIC TARGET?

AUTHOR INFORMATION
Russell P. Tracy, PhD; Lewis H. Kuller, MD, MPH

RELATED ARTICLE

High Attributable Risk of Elevated C-Reactive Protein Level to Conventional Coronary Heart Disease Risk Factors: The Third National Health and Nutrition Examination Survey
Michael Miller, Min Zhan, and Stephen Havas
Arch Intern Med. 2005;165(18):2063-2068.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

C-Reactive Protein and Cardiovascular Risk in the Metabolic Syndrome and Type 2 Diabetes: Controversy and Challenge
Capuzzi and Freeman
Clin. Diabetes 2007;25:16-22.
ABSTRACT | FULL TEXT  

Do Traditional CHD Risk Factors Explain CRP Elevations?
Journal Watch Cardiology 2005;2005:1-1.
FULL TEXT